Cytomegalovirus infections : risk factors, causes and management [E-Book]
Series: Allergies and infectious diseasesPublisher: New York : Nova Biomedical : Nova Science Publishers, Inc., [2012]Description: 1 online resourceContent type:- text
- computer
- online resource
- 9781619422322
- 1619422328
Contents:
""CYTOMEGALOVIRUS INFECTIONS ""; ""CYTOMEGALOVIRUS INFECTIONS ""; ""Contents""; ""Preface""; ""Management of Human Cytomegalovirus Infection in Pregnancy""; ""Abstract""; ""1. Introduction""; ""2. Diagnosis of HCMV Infection""; ""2.1. Primary Infection""; ""2.2. Recurrent Infection""; ""3. Maternal Prognostic Markers of In Utero Transmission""; ""4. Invasive Procedures for Prenatal Diagnosis""; ""4.1. Amniocentesis""; ""4.2. Cordocentesis""; ""5. Fetal Prognostic Markers of Congenital Disease""; ""6. Fetal Imaging Techniques""; ""6.1. Ultrasound""; ""6.2. Magnetic Resonance Imaging""
""7. Therapeutic Interventions in Pregnancy""""8. Counseling""; ""Conclusion""; ""Acknowledgments""; ""References""; ""CMV and Male Infertility""; ""Abstract""; ""Introduction""; ""Viruses and Human Semen""; ""Cytomegalovirus (CMV)""; ""Conclusion""; ""References""; ""Cytomegalovirus and the Cognitive Immunity: An Old Married Couple for the Best and the Worst""; ""Abstract""; ""Abbreviations""; ""Introduction""; ""A. Effect of the Immunity on CMV Ecology""; ""B. CMV Infection Effects on the Immune Status""; ""CMV May Influence the Quality of the Immune System""
""Chronic Pro-Inflammatory Effect and Ageing""""CMV Participates in Senescence of the Immune System Itself""; ""CMV Induces the Emergence of Unconventional Phenotypes""; ""CMV Infection and Lymphoproliferative Disorders""; ""Conclusion""; ""References""; ""Human Cytomegalovirus Infection: Risk Factors, Diagnosis, and Impact on Immunity and Health""; ""Abstract""; ""Introduction""; ""Risk Factors for HCMV Infection and Reactivation""; ""Diagnosis""; ""Impact on Immunity and Health""; ""Conclusion""; ""Acknowledgment""; ""References""; ""Immunity to Human Cytomegalovirus""; ""Abstract""
""Introduction""""Immune Response to HCMV Infection""; ""Age-Related HCMV Immunity""; ""HCMV Infection in Immunocompromised Individuals""; ""a) HCMV and Primary Immunodeficiences""; ""b) HCMV in HIV-Positive Individuals""; ""c) HCMV and Transplantation""; ""Immunologic Monitoring for HCMV""; ""References""; ""Antiviral and Vaccine Strategies against Cytomegalovirus: Current Therapies and Future Directions""; ""Abstract""; ""1. Introduction""; ""1.1. CMV Disease""; ""1.2. Virus Structure""; ""2. CMV Antivirals""; ""2.1. CMV Antiviral Ganciclovir and Prodrug""
""2.2. Other Licensed CMV Antivirals""""3. Improving on Current Antivirals and Development of New Antivirals""; ""3.1. Beyond Cidofovir""; ""3.2. Methylenecyclopropane Nucleosides""; ""3.3. Maribavir""; ""3.4. Other UL97 mediated CMV Antivirals""; ""3.5. CMV DNA Terminase Complex and Antivirals""; ""3.6. CMV Antivirals and High Throughput Screening""; ""3.7. RNAi and CMV Antiviral Therapy""; ""3.8. Peptide Based CMV Antivirals""; ""3.9. Thymidine Kinase Antivirals and CMV""; ""3.10. CMV Hyper-Immune Globulin Therapy and Congenital Infection""; ""3.11. CMV and Off Label Drug Therapy""
| Item type | Home library | Class number | URL | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|
| Electronic book | Stenhouse Library (Kingston Hospital) Online | Link to resource | Available |
Includes bibliographical references and index.
""CYTOMEGALOVIRUS INFECTIONS ""; ""CYTOMEGALOVIRUS INFECTIONS ""; ""Contents""; ""Preface""; ""Management of Human Cytomegalovirus Infection in Pregnancy""; ""Abstract""; ""1. Introduction""; ""2. Diagnosis of HCMV Infection""; ""2.1. Primary Infection""; ""2.2. Recurrent Infection""; ""3. Maternal Prognostic Markers of In Utero Transmission""; ""4. Invasive Procedures for Prenatal Diagnosis""; ""4.1. Amniocentesis""; ""4.2. Cordocentesis""; ""5. Fetal Prognostic Markers of Congenital Disease""; ""6. Fetal Imaging Techniques""; ""6.1. Ultrasound""; ""6.2. Magnetic Resonance Imaging""
""7. Therapeutic Interventions in Pregnancy""""8. Counseling""; ""Conclusion""; ""Acknowledgments""; ""References""; ""CMV and Male Infertility""; ""Abstract""; ""Introduction""; ""Viruses and Human Semen""; ""Cytomegalovirus (CMV)""; ""Conclusion""; ""References""; ""Cytomegalovirus and the Cognitive Immunity: An Old Married Couple for the Best and the Worst""; ""Abstract""; ""Abbreviations""; ""Introduction""; ""A. Effect of the Immunity on CMV Ecology""; ""B. CMV Infection Effects on the Immune Status""; ""CMV May Influence the Quality of the Immune System""
""Chronic Pro-Inflammatory Effect and Ageing""""CMV Participates in Senescence of the Immune System Itself""; ""CMV Induces the Emergence of Unconventional Phenotypes""; ""CMV Infection and Lymphoproliferative Disorders""; ""Conclusion""; ""References""; ""Human Cytomegalovirus Infection: Risk Factors, Diagnosis, and Impact on Immunity and Health""; ""Abstract""; ""Introduction""; ""Risk Factors for HCMV Infection and Reactivation""; ""Diagnosis""; ""Impact on Immunity and Health""; ""Conclusion""; ""Acknowledgment""; ""References""; ""Immunity to Human Cytomegalovirus""; ""Abstract""
""Introduction""""Immune Response to HCMV Infection""; ""Age-Related HCMV Immunity""; ""HCMV Infection in Immunocompromised Individuals""; ""a) HCMV and Primary Immunodeficiences""; ""b) HCMV in HIV-Positive Individuals""; ""c) HCMV and Transplantation""; ""Immunologic Monitoring for HCMV""; ""References""; ""Antiviral and Vaccine Strategies against Cytomegalovirus: Current Therapies and Future Directions""; ""Abstract""; ""1. Introduction""; ""1.1. CMV Disease""; ""1.2. Virus Structure""; ""2. CMV Antivirals""; ""2.1. CMV Antiviral Ganciclovir and Prodrug""
""2.2. Other Licensed CMV Antivirals""""3. Improving on Current Antivirals and Development of New Antivirals""; ""3.1. Beyond Cidofovir""; ""3.2. Methylenecyclopropane Nucleosides""; ""3.3. Maribavir""; ""3.4. Other UL97 mediated CMV Antivirals""; ""3.5. CMV DNA Terminase Complex and Antivirals""; ""3.6. CMV Antivirals and High Throughput Screening""; ""3.7. RNAi and CMV Antiviral Therapy""; ""3.8. Peptide Based CMV Antivirals""; ""3.9. Thymidine Kinase Antivirals and CMV""; ""3.10. CMV Hyper-Immune Globulin Therapy and Congenital Infection""; ""3.11. CMV and Off Label Drug Therapy""
Master record variable field(s) change: 050, 082
There are no comments on this title.
Log in to your account to post a comment.
London Health Libraries Consortium Privacy notice and Membership terms and conditions